Updates in characteristics and survival rates of cirrhosis in a nationwide cohort of real-world U.S. patients, 2003-2021.
Sally TranBiyao ZouKeeSeok LeeLeslie KamYee Hui YeoLinda HenryRamsey CheungMindie H NguyenPublished in: Alimentary pharmacology & therapeutics (2024)
HCC incidence and survival vary by aetiology among patients with cirrhosis, with cryptogenic cirrhosis having the lowest survival and lower survival in the more recent time period.